Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.68 |
| ▸ | MAPT | P10636 | 5/20 | 0.68 |
| ▸ | MEN1 | O00255 | 4/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.68 |
| ▸ | AR | P10275 | 1/20 | 0.68 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.56 |
| ▸ | TSHR | P16473 | 3/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.56 |
| ▸ | GAA | P10253 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | GFER | P55789 | 1/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.56 |
| ▸ | ALOX12 | P18054 | 3/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.55 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.55 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1686500 | 0.93 | MEN1 (0.55) | ALDH1A1MAPTMEN1KMT2AAR | |
| SCHEMBL25692156 | 0.83 | ALDH1A1 (0.46) | ALDH1A1MAPTMEN1KMT2AAR | |
| SCHEMBL32665149 | 0.83 | CYP3A4 (0.53) | ALDH1A1MAPTMEN1KMT2AAR | |
| SCHEMBL678299 | 0.82 | ALDH1A1 (1.00) | ALDH1A1MAPTMEN1KMT2AAR | |
| SCHEMBL16621392 | 0.81 | AKR1C3 (0.53) | ALDH1A1MAPTMEN1KMT2AAR | |
| SCHEMBL32665516 | 0.78 | RAB9A (0.61) | ALDH1A1MAPTMEN1KMT2ATDP1 | |
| SCHEMBL8795249 | 0.77 | SIGMAR1 (0.46) | ALDH1A1MAPTMEN1KMT2AAR | |
| SCHEMBL9440409 | 0.77 | ALDH1A1 (0.72) | ALDH1A1MAPTMEN1KMT2AAR | |
| SCHEMBL24137804 | 0.76 | MAPT (0.52) | ALDH1A1MAPTMEN1KMT2AAR | |
| SCHEMBL7298939 | 0.76 | MAPT (0.62) | ALDH1A1MAPTMEN1KMT2AHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109422770-B | Boron-containing heterocyclic compounds for OLEDs, organic light emitting devices, and compound formulations comprising the same | 北京夏禾科技有限公司 | 2022-03-11 | — | — | CN | disclosed |
| US-10998506-B2 | Boron containing heterocyclic compound for OLEDs, an organic light-emitting device, and a formulation comprising the boron-containing heterocyclic compound | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2021-05-04 | — | — | US | disclosed |
| US-10998506-B2 | Boron containing heterocyclic compound for OLEDs, an organic light-emitting device, and a formulation comprising the boron-containing heterocyclic compound | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2021-05-04 | — | — | US | disclosed |
| US-6914122-B2 | Macrocyclic NS-3 serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties | SCHERING CORPORATION (US) | 2005-07-05 | — | — | US | disclosed |
| EP-1274724-A2 | MACROCYCLIC NS3-SERINE PROTEASE INHIBITORS OF HEPATITIS C VIRUS COMPRISING ALKYL AND ARYL ALANINE P2 MOIETIES | SCHERING CORPORATION (US) | 2003-01-15 | — | — | EP | disclosed |
| US-20020016294-A1 | Macrocyclic NS-3 serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties | SCHERING CORPORATION | 2002-02-07 | — | — | US | disclosed |
| WO-2001081325-A2 | MACROCYCLIC NS3-SERINE PROTEASE INHIBITORS OF HEPATITIS C VIRUS COMPRISING ALKYL AND ARYL ALANINE P2 MOIETIES | SCHERING CORPORATION (US) | 2001-11-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10998506-B2 | Boron containing heterocyclic compound for OLEDs, an organic light-emitting device, and a formulation comprising the boron-containing heterocyclic compound | OCIAD2, OCIAD1, SBDS | ALDH1A1 2620/4885MAPT 899/4885MEN1 2469/4885 |
| US-20020016294-A1 | Macrocyclic NS-3 serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties | PRSS3, HPN, DPP3 | ALDH1A1 3217/4885MAPT 4377/4885MEN1 4509/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.